<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00428363</url>
  </required_header>
  <id_info>
    <org_study_id>EK2512001</org_study_id>
    <nct_id>NCT00428363</nct_id>
  </id_info>
  <brief_title>Effect of Optic Edge Design in a Silicone Intraocular Lens on Posterior Capsule Opacification</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medical University of Vienna</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medical University of Vienna</source>
  <brief_summary>
    <textblock>
      Purpose: To compare the posterior capsule opacification (PCO) inhibiting effect of the sharp
      posterior optic edge design of the Clariflex silicone intraocular lens (IOL) with that of the
      double-round edge design of the SI40 (Phacoflex) silicone IOL over a period of 3 years.

      Setting: Department of Ophthalmology, Medical University of Vienna, Vienna, Austria.

      Methods: Fifty-two patients with bilateral age-related cataract (104 eyes) were included in
      this randomized, prospective, bilateral, patient- and examiner-masked clinical trial with
      intra-individual comparison. Each study patient had cataract surgery in both eyes and
      received an SI40 IOL (anterior and posterior round optic edges) in one eye and a Clariflex
      IOL with OptiEdge (round anterior and sharp posterior optic edge) in the other eye. Follow-up
      examinations were at one week, one month, six months, one, two, and three years. Digital
      retroillumination images were taken of each eye. The amount of PCO was assessed subjectively
      at the slit-lamp and objectively using automated image analysis software (AQUA) one, two, and
      three years after surgery.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>June 2001</start_date>
  <completion_date>March 2006</completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double</masking>
  </study_design_info>
  <primary_outcome>
    <measure>amount of posterior capsule opacification (objective and subjective score 0-10)</measure>
  </primary_outcome>
  <secondary_outcome>
    <measure>visual acuity</measure>
  </secondary_outcome>
  <enrollment>52</enrollment>
  <condition>Cataract</condition>
  <condition>Pseudophakia</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Cataract surgery with implantation of an intraocular lens</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  bilateral, age related cataract

        Exclusion Criteria:

          -  history of other ocular disease or intraocular surgery

          -  diabetes requiring medical control
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Rupert Menapace, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Medical University of Vienna</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Oliver Findl, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Medical University of Vienna</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Dept. of Ophthalmology, Medical University of Vienna</name>
      <address>
        <city>Vienna</city>
        <zip>1090</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Austria</country>
  </location_countries>
  <link>
    <url>http://www.meduniwien.ac.at/iol/</url>
    <description>Homepage of the Vienna IOL Study Group (Dept. of Ophthalmology, Medical University of Vienna)</description>
  </link>
  <reference>
    <citation>Buehl W, Findl O, Menapace R, Rainer G, Sacu S, Kiss B, Petternel V, Georgopoulos M. Effect of an acrylic intraocular lens with a sharp posterior optic edge on posterior capsule opacification. J Cataract Refract Surg. 2002 Jul;28(7):1105-11.</citation>
    <PMID>12106717</PMID>
  </reference>
  <reference>
    <citation>Buehl W, Findl O, Menapace R, Sacu S, Kriechbaum K, Koeppl C, Wirtitsch M. Long-term effect of optic edge design in an acrylic intraocular lens on posterior capsule opacification. J Cataract Refract Surg. 2005 May;31(5):954-61.</citation>
    <PMID>15975461</PMID>
  </reference>
  <results_reference>
    <citation>Buehl W, Menapace R, Sacu S, Kriechbaum K, Koeppl C, Wirtitsch M, Georgopoulos M, Findl O. Effect of a silicone intraocular lens with a sharp posterior optic edge on posterior capsule opacification. J Cataract Refract Surg. 2004 Aug;30(8):1661-7.</citation>
    <PMID>15313288</PMID>
  </results_reference>
  <verification_date>January 2007</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 29, 2007</study_first_submitted>
  <study_first_submitted_qc>January 29, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 30, 2007</study_first_posted>
  <last_update_submitted>January 29, 2007</last_update_submitted>
  <last_update_submitted_qc>January 29, 2007</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 30, 2007</last_update_posted>
  <keyword>posterior capsule opacification</keyword>
  <keyword>PCO</keyword>
  <keyword>after cataract</keyword>
  <keyword>intraocular lens</keyword>
  <keyword>optic edge design</keyword>
  <keyword>sharp optic edge</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cataract</mesh_term>
    <mesh_term>Capsule Opacification</mesh_term>
    <mesh_term>Pseudophakia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

